Sanofi/SAN

-0.23%
-
1D1W1MYTD1YMAX

About Sanofi

Sanofi SA is a France-based healthcare company based in France. The Company focuses on patient needs and engages in the research, development, manufacture, and marketing of therapeutic solutions. Its three operating segments are: Pharmaceuticals, Consumer Healthcare (CHC), and Vaccines. The Pharmaceuticals includes: Immunology, Multiple Sclerosis / Neurology, Oncology, Rare Diseases, Rare Blood Disorders, Cardiovascular, Diabetes, Established Prescription Products. The Vaccines segment comprises, for all geographical territories, the commercial operations of Sanofi Pasteur, together with research, development, and production activities dedicated to vaccines. The CHC segment comprises the commercial operations for Sanofi’s Consumer Healthcare products, together with research, development and production activities dedicated to those products. The Company’s products developed in collaboration or franchise include Dupixent, Aubagio, Lemtrada, Cerezyme, Lumizyme, Jevtana, Fabrazyme.

Ticker

SAN

Sector

Healthcare

Trading on

PAR

Industry

Biotechnology & Drugs

CEO

Paul Hudson

Employees

87,994

Headquarters

Paris, France

Sanofi Metrics

BasicAdvanced
€109.38B
Market cap
20.11
P/E ratio
€4.30
EPS
0.53
Beta
€3.76
Dividend rate
4.35%
Dividend yield
€109.38B
0.53021
€105.18
€80.60
1.35M
€3.76
1.267
0.868
21.748
24.881
87.13%
66.19%
4.38%
7.26%
5.43%
20.11
2.355
1.461
345.032
39.344
3.9%
4.35%
4.35%
2.32%
-35.42%
7.52%
-23.91%
5.52%

What the Analysts think about Sanofi

Analyst Ratings

Majority rating from 26 analysts.
Buy

Price Targets

Average projection from 23 analysts.
19.46% upside
High €125.00
Low €56.00
€86.47
Current price
€103.30
Average price target

Sanofi Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
7.91% profit margin
QuarterlyAnnual
Q4 23
QoQ growth
Revenue
€24.9B
96.09%
Net income
€1.97B
-21.98%
Profit margin
7.91%
-60.21%

Sanofi Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 1.44%
QuarterlyAnnual
Q1 23
Q2 23
Q3 23
Q4 23
Q1 24
Actual
€2.16
€1.74
€2.55
€1.66
-
Expected
€2.01
€1.67
€2.58
€1.68
€1.73
Surprise
7.38%
4.31%
-1.34%
-1.44%
-
Latest price is delayed by 15 minutes. Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by ICE Data Services and Euronext. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

FAQs

What’s the current market cap for Sanofi stock?

Sanofi (SAN) has a market cap of €109.38B as of April 15, 2024.

What is the P/E ratio for Sanofi stock?

The price to earnings (P/E) ratio for Sanofi (SAN) stock is 20.11 as of April 15, 2024.

Does Sanofi stock pay dividends?

Yes, the Sanofi (SAN) stock pays dividends to shareholders. As of April 15, 2024, the dividend rate is €3.76 and the yield is 4.35%. Sanofi has a payout ratio of 87.13% on a trailing twelve-month basis.

When is the next Sanofi dividend payment date?

The next Sanofi (SAN) dividend payment is scheduled for May 15, 2024.

What is the beta indicator for Sanofi?

Sanofi (SAN) has a beta rating of 0.53. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

What is the Sanofi stock price target?

The target price for Sanofi (SAN) stock is €103.3, which is 19.46% above the current price of €86.47. This is an average based on projections from 23 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell Sanofi stock

Buy or sell Sanofi stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing